The global non-invasive surgical wound closure market is anticipated to grow steadily, with its valuation projected to increase from approximately USD 2.47 billion in 2025 to nearly USD 3.70 billion by 2035. This growth corresponds to a CAGR of 4.1% over the forecast period.
The rising demand for minimally invasive surgical procedures and the need for efficient wound healing solutions are key factors driving the expansion of this market. Non-invasive wound closure techniques offer advantages such as reduced infection risk, faster recovery times, and improved cosmetic outcomes compared to traditional sutures and staples.
The market growth is fueled by increasing surgical procedures globally, including laparoscopic and robotic surgeries, which favor non-invasive wound closure methods. These techniques are widely adopted across various medical specialties such as general surgery, orthopedics, cardiovascular, and gynecology. The growing emphasis on outpatient surgeries and shorter hospital stays further supports the demand for quick and effective wound closure systems.
Product segmentation includes adhesive tapes, tissue adhesives, surgical sealants, and wound closure strips. Adhesive tapes and tissue adhesives dominate due to their ease of application and ability to reduce patient discomfort. Tissue adhesives, in particular, are gaining popularity for their ability to provide strong, flexible closure while minimizing scarring and inflammation. Innovations in biocompatible and bioresorbable materials are enhancing the efficacy and safety profiles of these products.
In March 2024, Advanced Medical Solutions (AMS) launched LIQUIFIX™, an innovative hernia mesh fixation device, in the USA Developed under the LiquiBandFix8® brand, LIQUIFIX™ utilizes precise cyanoacrylate adhesive drops for secure internal mesh placement, eliminating the need for traditional sutures or staples.
The USA launch was facilitated through a strategic partnership with TELA Bio, Inc., and initial market response has been positive, with early orders surpassing expectations. The company anticipates further growth with upcoming approvals from major USA Group Purchasing Organizations (GPOs) expected by mid-2025.
Sustainability and safety remain important focus areas for manufacturers. The development of environmentally friendly, non-toxic, and hypoallergenic materials aligns with evolving regulatory standards and consumer expectations. Moreover, improvements in packaging and sterilization technologies contribute to product reliability and usability.
Challenges such as high product costs, reimbursement issues, and the need for clinician training may limit market growth in some regions. Nevertheless, continuous research, development efforts, and increasing adoption of advanced wound closure technologies are expected to mitigate these barriers.
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 2.37 billion |
| Estimated Size, 2025 | USD 2.47 billion |
| Projected Size, 2035 | USD 3.70 billion |
| Value-based CAGR (2025 to 2035) | 4.1% |
Comparative analysis of fluctuations in compound annual growth rate (CAGR) for the global non-invasive surgical wound closure sales between 2024 and 2025 on six months basis is shown below.
By this examination, major variations in the performance of these markets are brought to light, and also trends of revenue generation are captured hence offering stakeholders useful ideas on how to carry on with the market's growth path in any other given year. January through June covers the first part of the year called half1 (H1), while half2 (H2) represents July to December
The table presents the expected CAGR for the global non-invasive surgical wound closure sales over several semi-annual periods spanning from 2025 to 2035. In the first half (H1) of the decade from 2025 to 2035, the business is predicted to surge at a CAGR of 4.8%, followed by a slightly slower growth rate of 4.5% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 4.8% (2024 to 2034) |
| H2 | 4.5% (2024 to 2034) |
| H1 | 4.1% (2025 to 2035) |
| H2 | 3.6% (2025 to 2035) |
Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 4.1% in the first half and decrease moderately at 3.6% in the second half. In the first half (H1) the market witnessed a decrease of 70 BPS while in the second half (H2), the market witnessed a decrease of 90 BPS.
The adhesive segment is expected to hold a commanding 56.4% market share in 2025, maintaining dominance in the non-invasive surgical wound closure market. Adhesives are favored for their ease of application and versatility across various surgical procedures, especially in cosmetic and aesthetic surgeries where minimal scarring is paramount.
Compared to sutures and staples, adhesives leave smaller, less conspicuous scars, enhancing patient satisfaction. Additionally, their application and removal are less painful, improving overall patient comfort and reducing the need for follow-up visits. Adhesives also create an effective protective seal over wounds, significantly lowering infection risks.
Technological advancements, including bioactive and synthetic adhesives, further strengthen this segment’s growth prospects. The ongoing innovation improves adhesive performance, such as faster curing times and enhanced flexibility, allowing use in diverse clinical settings. As awareness grows about the benefits of non-invasive wound closures, adhesives continue to gain traction among surgeons and patients alike, positioning this segment for sustained growth through the forecast period.
The hospitals segment is projected to capture approximately 48.4% market share in 2035, reflecting its status as the largest end user of non-invasive surgical wound closure products. Hospitals conduct a wide variety of surgical procedures, including general, orthopedic, cosmetic, and aesthetic surgeries, driving consistent demand for versatile and efficient wound closure solutions.
High surgery volumes necessitate reliable, easy-to-use products that enhance patient outcomes and reduce recovery times. Non-invasive closures contribute to faster healing and shorter hospital stays, improving overall healthcare efficiency. Additionally, hospitals have greater access to advanced wound care technologies, which promotes adoption of the latest closure solutions.
The segment’s growth is supported by increasing surgical procedure volumes globally, coupled with heightened focus on patient safety and infection control. As hospitals strive to improve surgical success rates and patient satisfaction, their demand for innovative non-invasive wound closure products is expected to rise steadily, securing this segment’s dominant position in the market over the forecast period.
Increase in adoption of Non-invasive Surgical Wound Closure in cosmetic and aesthetic surgeries Surges the growth of the market
Cosmetic procedures, such as facelifts, eyelid surgeries, and body contouring, requires minimally noticeable wound closures which has to be done precisely. Non-invasive adhesives in skin such as strips of adhesive tape are bioengineered in such a way that they leave fewer or no scars with faster healing process.
As patients demand quicker recovery, less visible scarring, and enhanced comfort after aesthetic treatments, non-invasive closures are an attractive alternative. They eliminate the process of painful stitch removals, lower the risk of infections, and minimize post-surgical discomfort, which makes them one of the preferred choice among cosmetic surgeons.
The demand for minimally invasive procedures and improving patient satisfaction with the process is also causing a trend in the non-invasive wound closure method in the aesthetic industry. This growing adoption of non-invasive surgical wound closure products in the cosmetic and aesthetic industry anticipate the growth of the market.
Strategic collaboration for expansion of their product reach anticipate the growth of the Market
Strategic partnerships are contributing a lot to the increase of the non-invasive surgical wound closure products reach and penetration. It has helped increase market growth as it helps companies get in touch with the target audience by collaborating with healthcare providers, surgical centers, and medical device companies.
These collaborations help firms tap into established distribution channels, reducing barriers to entry in various regions, particularly emerging markets where demand for advanced wound care solutions increases.
In addition, co-operation with research institutions and universities can foster innovation on non-invasive technologies resulting in the creation of more efficient, productized solutions specific to special needs in surgery. Together with this, such collaborative works allow companies to apply novel technologies like smart wound care or bioactive dressings onto their product lines and, thus, enable offering more holistic and cutting-edge solutions.
It also increases product presence in specialized fields such as aesthetic and cosmetic surgery through hospitals and cosmetic surgery clinics where the demand for the non-invasive wound-closing methods is on a rising trend. These strategic partnerships have the potential to hasten the adoption of non-invasive surgical wound closure products and increase market share to lead to growth.
For instance, in April 2020, BandGrip collaborated with Medline and signed a distribution partnership for expansion of their unique patented micro-anchor skin closure technology products.
Growing Advancement in Non-invasive skin closure device can bring new business growth opportunities to the Market players
Innovations in adhesive technologies, bioengineered dressings, and mechanical devices improve healing times, by reduced scarring, and enhanced patient comfort. Use of alternatives that are non-invasive as compared to sutures and staples which are associated with longer recovery periods and complications such as infections, healthcare providers are turning to these alternatives in greater numbers.
These factors have encouraged manufacturers to focus on introduction of new products such as zip tie skin closure. The market is witnessing significant adoption of this products owing to its faster and efficient closure of wounds, especially in areas under high tension, with minimum trauma to the surrounding tissues. The adjustable nature of the zip tie system allows for precision tension control, which reduces the risk of wound dehiscence and promotes optimal healing.
Quick application is advantageous in surgeries with high volumes and in emergency settings where time is a significant factor. Additionally, the low dependency on specific training make it attractive in inpatient and outpatient care.
With the emphasis on minimally invasive and rapid healing techniques among healthcare professionals, surgical zip tie closures are expected to significantly increase the adoption of non-invasive wound closure devices.
Competition from traditional wound closure techniques hinders the growth of the market
Non-invasive surgical wound closure faces significant competition in its adoption from traditional wound closure techniques as they are been trusted by healthcare professionals for generations. They have proven track record of effectiveness, reliability, and familiarity. Many surgeons become accustomed to the use of sutures and staples; thus, changing their methods to non-invasive ones requires a change in practice.
Another point is that conventional closure methods are usually more affordable, especially in less privileged environments. Non-invasive products, especially more sophisticated ones like bioactive dressings or smart wound care technologies, are typically costlier, thus not as attractive in price-sensitive markets. This price difference could affect the uptake of non-invasive solutions, especially in hospitals or clinics that do not have much to spare.
In addition, traditional methods have set clinical guidelines and training, whereas non-invasive products require further education and validation, thus delaying the general acceptance of the product. The strong usage of traditional methods coupled with the fear of effectiveness and cost of non-invasive alternatives slows the overall growth of the market.
The global sales of non-invasive surgical wound closure devices recorded a CAGR of 3.2% during the historical period between 2020 and 2024. The revenue growth was positive as it reached a value of USD 2.37 billion in 2024 from USD 2.01 billion in 2020.
Non-invasive surgical wound closure technique are generally used for the closure of surgical wounds without using any sutures, or staples. These technique has an inclusion of skin adhesive, bioengineered dressings, and surgical zip ties which work as an alternative to the traditional wound closure techniques.
The change in surgical practices towards more minimally invasive surgeries significantly contributes to the growth of the market. Its minimal size and precision nature, have attributed to its growing demand in the market. Increase in focus of manufacturers on the development of adhesive technologies and materials, including cyanoacrylate-based adhesives that provide secure and reliable closure without stitches anticipates the growth of the market.
This growing adoption by health professionals is due to faster recovery times, lower rates of complications such as infection, and more pleasing aesthetic outcomes for the patient. In these methods, scarring is much lower compared to other areas such as plastic and cosmetic surgery.
Bioactive and antimicrobial dressings are still on the current trends list, along with integration of smart wound care technologies. Non-invasive methods continue to increase in outpatient and emergency surgeries. The comfort it affords to the patient combined with its efficiency will help the market grow in the future as awareness, cost-effectiveness, and innovation are improved.
Tier 1 companies comprise market leaders with a market revenue of above USD 100 million capturing significant market share of 64.6% in global market. These market leaders are characterized by high production capacity and a wide product portfolio.
These market leaders are distinguished by their extensive expertise in manufacturing and reconditioning across multiple packaging formats and a broad geographical reach, underpinned by a robust consumer base. Prominent companies within tier 1 include 3M Corporation, Baxter International Inc., Johnson and Johnson (Ethicon)
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions and highly influencing the local market and holds around 31.7% market share. These are characterized by a strong presence overseas and strong market knowledge.
These market players have good manufacturing technology and ensure regulatory compliance but may not have access to global reach. Prominent companies in tier 2 include Smith+Nephew, Medtronic, Aesculap AG & Co.KG
Finally, Tier 3 companies, act as a suppliers to the established market players. They specialize in specific products for catering to the niche markets.
Overall, Tier 1 companies are the primary drivers of the market, where Tier 2 and 3 companies make significant contributions, to the market ensuring the market remains dynamic and competitive.
The section below covers the industry analysis for the non-invasive surgical wound closure market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided.
The United States is anticipated to remain at the forefront in North America, with a value share of 58.7% through 2035. In Asia Pacific, China is projected to witness a CAGR of 5.8% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| UK | 3.4% |
| China | 5.8% |
| Japan | 4.2% |
| South Korea | 4.6% |
| Germany | 2.3% |
| India | 5.6% |
| Saudi Arabia | 3.8% |
USA market is poised to exhibit a substantial CAGR during the forecast period. Currently, it holds the highest share in the North American market, and the trend is expected to continue during the forecast period.
Minimally invasive procedures, such as robotic surgery, have grown in number, which has led to increase in demand for solutions that has ability to make wound closure with reduced incision. These are better suited with non-invasive methods of closure like skin adhesives and adhesive strips since they are known to provide rapid recovery time, minimal scarring, and a lower infection risk.
With the standardization of MIS among different surgical specialties, including general surgery and orthopedics, the demand for non-invasive wound closure products is expected to increase in the United States.
The applications bring benefits such as patient satisfaction and faster recovery times, making them increasingly used in healthcare, which is boosting the growth of this non-invasive wound closure systems market.
France currently holds around 36.4% share of the non-invasive surgical wound closure market. The market in France is anticipated to grow at a substantial CAGR throughout the forecast period.
The rising wave of adopting scarless surgeries in France is highly propelling the growth of the market. Scarless surgeries with minimal visible scarring as their goal and efficient result are increasingly adopted. For aesthetic and reconstructive treatments, non-invasive closure methods, such as adhesives for the skin, adhesive strips, and bioactive dressings, perfectly fit into the approach of scarless surgeries and support greater cosmetic outcomes and reduced time for recovery.
These products allow for smaller, cleaner incisions that heal faster and with less visible scarring, which is ideal for scarless surgery. The increasing demand for minimally invasive and aesthetic surgeries in France has seen health professionals look for non-invasive solutions to accommodate the preferences of patients on reduced scarring and faster healing.
This shift towards scarless procedures and non-invasive wound closures is anticipated to drive the market's growth, with benefits accruing to both patients and providers.
South Korea is expected to have a strong foothold when it comes to technology innovation. In 2024 the country is projected to account for substantial share of the non-invasive surgical wound closure market.
South Korea's increasing popularity for undergoing cosmetic and aesthetic surgeries enhances the growth in the use of non-invasive surgical wound closure products. Being one of the largest cosmopolitan centers of cosmetic procedure operations, with huge demands on facelift, eyelid, and body contouring operations, it offers a competitive advantage over others.
These patients seek minimal scarring and speedy recovery, making non-invasive methods of wound closure highly attractive, such as skin adhesives and bioactive dressings. Such methods reduce scarring, enhance faster healing, and decrease the risk of infection in comparison to traditional sutures and staples.
Furthermore, South Korea focuses on aesthetic outcomes, so non-invasive closures are preferred because they offer smoother, more aesthetically pleasing results. The growing demand for less invasive procedures and a greater emphasis on beauty and comfort are turning non-invasive wound closure products into the go-to solution in the country's cosmetic surgery sector, propelling market growth.
Substantial investments and focus is seen in this sector pertaining to non-invasive surgical wound closure which includes multiple product launches in this market. Another key strategic focus of these companies is to actively expand their geographical presence for strengthen their foothold in the market.
Recent Industry Developments in Non-invasive Surgical Wound Closure Market
| Report Attributes | Details |
|---|---|
| Current Total Market Size (2025) | USD 2.47 billion |
| Projected Market Size (2035) | USD 3.70 billion |
| CAGR (2025 to 2035) | 4.1% |
| Base Year for Estimation | 2024 |
| Historical Period | 2020 to 2024 |
| Projections Period | 2025 to 2035 |
| Quantitative Units | USD billion for value |
| Product Types Analyzed (Segment 1) | Adhesive, Natural, Synthetic, Adhesive Barrier Products, Hemostats, Mechanical, Active, Flowable, Sealants, Fibrin, Surgical |
| Applications Analyzed (Segment 2) | Orthopedics, Cosmetics, Obstetrics and Gynecology, Others |
| End Users Covered (Segment 3) | Hospitals, Clinics, Dermatological Clinics, Ambulatory Surgical Centers, Emergency Service Centers |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; Middle East & Africa |
| Countries Covered | United States, United Kingdom, Germany, France, China, India, Japan, South Korea, Saudi Arabia |
| Key Players Influencing the Market | 3M Corporation, Baxter International Inc., Johnson & Johnson (Ethicon), Smith & Nephew, Medtronic, Aesculap AG & Co. KG, Advanced Medical Solutions, Abbott Laboratories, Zipline Medical |
| Additional Attributes | Dollar sales by product type (adhesives, bioactive dressings), regional growth drivers, hospital vs. ASC demand patterns, demand in cosmetic surgery, strategic partnerships and innovation adoption |
| Customization and Pricing | Customization and Pricing Available on Request |
In terms of Product, the industry is divided into adhesive, natural, synthetic, adhesive barrier products, hemostats, mechanical, active, flowable, sealants, fibrin and surgical
In terms of Application, the industry is segregated orthopedics, cosmetics, obstetrics and gynecology and others
The industry is classified by end user as hospitals, clinics, dermatological clinics, ambulatory surgical centers and emergency service centers
Key countries of North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa (MEA) have been covered in the report.
The global sales of non-invasive surgical wound closure devices is projected to witness CAGR of 4.1% between 2025 and 2035.
The global sales of non-invasive surgical wound closure devices stood at USD 2.37 billion in 2024.
The overall revenue of non-invasive surgical wound closure devices is anticipated to reach USD 3.70 billion by 2035 end.
China is set to record the highest CAGR of 5.8% in the assessment period.
The key players operating in this sector include Advanced Medical Solutions Group Plc, Ethicon Endo-Surgery, Inc, Abbott Laboratories, Baxter International Inc., Medtronic, Inc., CP Medical, Inc., Aesculap AG & Co.KG, Smith & Nephew, Surgical Specialties Corporation, Derma Sciences, Inc., Teleflex Medical OEM, Zipline Medical, Inc, Medi-zip GmbH, Takeda Pharmaceuticals International GmbH (Nycomed Pharma GmbH), BSN Medical, 3M Corporation and Pro-Motion Medical B.V.
Explore Therapeutic Device Insights
Non-invasive Surgical Wound Closure Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
